SMTL ID : 3r1q.1

CDK2 in complex with inhibitor KVR-1-102

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.85 Å

Oligo State

monomer

Ligands

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 3 residues within 4Å: Chain A: E.265, R.268, S.269 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:R.268 Water bridges: A:E.265, A:R.268, A:S.269

1 x X75: 4-chloro-2-{[(6-chloropyridin-3-yl)methyl]amino}-5-nitrobenzamide(Non-covalent)

X75.2: 11 residues within 4Å: Chain A: I.18, V.26, A.39, K.41, V.72, F.88, E.89, F.90, L.91, H.92, L.142 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:I.18, A:A.39, A:L.142 Hydrogen bonds: A:E.89, A:L.91, A:L.91 Water bridges: A:D.153

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schonbrunn, E. et al., Structure-guided optimization of novel CDK2 inhibitors discovered by high-throughput screening. To be Published

Release Date

2012-08-08

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2

Related Entries With Identical Sequence